Reviva Pharmaceuticals Holdings, Inc. (RVPH) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.8M | -5.8M | -5.59M | -5.01M | -8.19M | -9.1M | -4.24M | -8.48M | -11.73M | -8.88M | -6.18M | -5.32M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 53.61% | 36.29% | -31.78% | 40.86% | 30.12% | -2.52% | 31.36% | -59.41% | -47.47% | -89.24% | -54.41% | -32.89% |
| Net Income | -3.2M | -3.37M | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M | -7.86M | -7.43M | -9.72M | -11.35M | -12.44M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 584.44K | 455.08K | 458.38K | 395.28K | 919.12K | 554.22K | 348.06K | 358.99K | 369.07K | 390.6K | 350.41K | 2.62M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 215.3K | -44.51K | 27.82K | -11.13K | -61.19K | 11.13K | -72.32K | -200.27K | -456.18K | -1.13M | -139.08K | 456.18K |
| Working Capital Changes | -1.41M | -2.84M | -2.06M | 656.71K | -2.62M | -3.41M | 3.85M | -774.99K | -4.21M | 1.58M | 4.96M | 4.05M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -976.35K | -2.2M | 325.33K | 26.53K | -1.56M | -2.64M | 4.08M | -1.03M | 1.87M | 0 | 2.63M | -212.29K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 11.55M | 7.05M | 8.41M | 10.09M | 7.27K | 17.02M | 3.62M | 2.68M | 332K | 27.27M | 0 | 5.21M |
| Debt Issued (Net) | -175.6K | 458.15K | -113.25K | -111.05K | -233.85K | 375.15K | -124.5K | -124.5K | 332K | -222.5K | 0 | - |
| Equity Issued (Net) | 11.73M | 6.65M | 8.52M | 10.2M | 241.13K | 16.64M | 3.75M | 2.81M | 0 | 27.49M | 0 | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -51.28K | 0 | 0 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 7.75M | 1.26M | 2.82M | 5.07M | -8.19M | 7.92M | -619.36K | -5.8M | -11.39M | 18.4M | -6.18M | -103.97K |
| Free Cash Flow | -3.8M | -5.8M | -5.59M | -5.01M | -8.19M | -9.1M | -4.24M | -8.48M | -11.73M | -8.88M | -6.18M | -5.32M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 53.61% | 36.29% | -31.78% | 40.86% | 30.12% | -2.52% | 31.36% | -59.41% | -47.47% | -89.24% | -54.41% | -32.89% |
| FCF per Share | -0.54 | -1.60 | -1.54 | -2.01 | -3.37 | -5.49 | -2.51 | -5.55 | -7.85 | -6.52 | -5.14 | -4.74 |
| FCF Conversion (FCF/Net Income) | 1.19x | 1.72x | 1.39x | 0.83x | 1.27x | 1.45x | 0.51x | 1.08x | 1.58x | 0.91x | 0.59x | 0.43x |
| Interest Paid | 6.65K | -5.62K | 4.8K | 4.07K | 10.16K | 4.71K | 5.15K | 5.15K | 3.49K | 10.21K | 0 | - |
| Taxes Paid | 675 | -3.37K | 0 | 2.29K | 1.07K | -3.42K | 0 | 2.76K | 657 | 1.08K | 14.73K | - |